Sabby Management, LLC Pharma Cyte Biotech, Inc. Transaction History

Sabby Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.01 - $2.34 $29,649 - $34,517	-14,751 Reduced 15.19%	82,373 $177,000
Q3 2023 Nov 14, 2023	BUY	$2.09 - $2.89 $202,989 - $280,688	97,124 New	97,124 $203,000
Q4 2022 Feb 14, 2023	SELL	$2.72 - $3.07 $1.28 Million - $1.44 Million	-469,622 Reduced 82.74%	97,978 $287,000
Q3 2022 Nov 14, 2022	SELL	$2.24 - $2.85 $1.11 Million - $1.41 Million	-493,811 Reduced 46.52%	567,600 $1.36 Million
Q2 2022 Aug 15, 2022	SELL	$1.99 - $2.33 $425,973 - $498,752	-214,057 Reduced 16.78%	1,061,411 $2.38 Million

Q1 2022 May 16, 2022	BUY	$1.91 - $2.77 $110,092 - $159,662	57,640 Added 4.73%	1,275,468 $2.93 Million
Q4 2021 Feb 14, 2022	BUY	$2.4 - $3.19 $498,436 - $662,505	207,682 Added 20.56%	1,217,828 $3.05 Million
Q3 2021 Nov 15, 2021	BUY	$2.28 - $16.9 $2.3 Million - $17.1 Million	1,010,146 New	1,010,146 $3.2 Million

1.07M

5.4K

400

Ticker PMCB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,750,100
Market Cap $41.5M
Description
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.